iRhythm Technologies, Inc. (IRTC) Financials
IRTC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 909.8 million | 819.5 million |
2023-12-31 | 433.1 million | 223.0 million |
2023-09-30 | 439.8 million | 220.0 million |
2023-06-30 | 429.5 million | 205.6 million |
IRTC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -61.8 million | ? |
2023-12-31 | -29.5 million | 23.8 million |
2023-09-30 | -7.9 million | 21.0 million |
2023-06-30 | -14.0 million | 14.1 million |
IRTC Net Income
No data available :(
IRTC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 569.1 million | - | - |
2023-12-31 | 133.8 million | - | 94.9 million |
2023-09-30 | 158.5 million | - | 96.8 million |
2023-06-30 | 164.7 million | 34.9 million | 94.3 million |
IRTC Shares Outstanding
IRTC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 9.8 million | 17.0 million | - | - |
2023-12-31 | 13.5 million | 15.4 million | 100.1 million | - |
2023-09-30 | 9.1 million | 16.3 million | 93.8 million | - |
2023-06-30 | 9.4 million | 13.7 million | 91.4 million | - |
IRTC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 131.9 million | 44.4 million |
2023-12-31 | 132.5 million | 45.1 million |
2023-09-30 | 124.6 million | 42.1 million |
2023-06-30 | 124.1 million | 37.9 million |
IRTC
Price: $102.68
52 week price:
Earnings Per Share: -4.04 USD
P/E Ratio: -35.28
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Volume: 71775
Ebitda: -10.3 millionMarket Capitalization: 3.2 billion